학술논문
Predictive cytokine biomarkers for survival in patients with advanced pancreatic cancer randomized to sequential chemoimmunotherapy comprising gemcitabine and capecitabine (GemCap) followed by the telomerase vaccine GV1001 compared to concurrent chemoimmunotherapy in the TeloVac phase III trial.
Document Type
Journal
Author
Neoptolemos, John P.; Greenhalf, William; Cox, Trevor F.; Costello, Eithne; Shaw, Victoria; Valle, Juan W.; Coxon, Fareeda Y.; Wadsley, Jonathan; Propper, David; Ross, Paul J.; Madhusudan, Srinivasan; Roques, Tom; Cunningham, David; Eatock, Martin McKinlay; Iveson, Tom; Patel, Kinnari; Garcia-Alonso, Angel; Nanson, Gemma; Middleton, Gary
Source
Subject
Language
English
ISSN
15277755